Navigation Links
ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
Date:5/27/2008

, and others have been pleased with our ability to answer important questions on a whole array of cancer and quality of life issues. This is achieved by having a diverse and full complement of reliable data sets that are assessed and analyzed by our experienced scientific team."

ACORN's unique data warehouse enables pharmacoeconomic and health outcomes analysis previously unachievable. "In addition to traditional sources of information, we have a unique component in our PACE PRO gathering capability which allows us to scientifically analyze patients' symptom burden and quality of life," states Mark Walker, PhD, Director of Scientific Management. "Historically, the analysis of treatments and outcomes, either clinical or economic across different patient populations, has not included rigorous measurements of patient-reported outcomes, both physical and psychological. In addition, Pharma and payer sectors are finding increased value from ACORN's immediate access to hundreds of thousands of oncology patients."

Analytical results are routinely published in peer-reviewed journals and presented at major scientific meetings. For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com


SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
2. Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
3. DuPont Expands Animal Health Solutions Business in Asia
4. Hospira Expands Board of Directors
5. Sidec AB Expands Into New Offices
6. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
7. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
8. Quintiles Consulting Business Expands
9. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
10. BrainCells Inc. Expands Series B Financing to $50 Million
11. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Lexington,Kentucky and Queens, New York (PRWEB) October 02, ... is pleased to announce funding received to ... pathway in Alzheimer’s disease. A grant award from ... Institute on Aging (NIA), National Institutes of Health ... as Novel AD Therapeutics." The company also received ...
(Date:10/2/2014)... The National Institutes of Health (NIH) ... today to develop an electrode array system that ... brain works through unprecedented resolution and scale. , ... to support President Obama's BRAIN (Brain Research through ... to revolutionize our understanding of the human mind ...
(Date:10/2/2014)... BRIDGEWATER, N.J. , Oct. 2, 2014 /PRNewswire/ ... in synthetic biology, and Amneal Pharmaceuticals LLC ... volume in the U.S., today announced the formation ... a target active pharmaceutical ingredient (API).  Utilizing Intrexon,s ... collaboration is to develop a consistent, scalable, and ...
(Date:10/1/2014)...  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the ... of high pressure-based sample preparation systems to the life ... to present at the 2 nd  Global Life ... The Conference will take place at the Warsaw Stock ... Schumacher , President and CEO of PBI, will present ...
Breaking Biology Technology:Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 2Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 2NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 4Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 2Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 4
... HAYWARD, Calif., Jan. 12 Anthera Pharmaceuticals, Inc., ... that it has completed enrollment in its 500 ... Cardiovascular,Inflammation Suppression) clinical trial designed to examine the ... 96 hours of an Acute,Coronary Syndrome (ACS) event. ...
... Md., Jan. 9 Human Genome Sciences, Inc. (Nasdaq: ... at the 27th Annual JPMorgan Healthcare Conference will be ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )A member of Human Genome ... the company on Wednesday, January 14, 2009 at 7:30 ...
... NS, Jan. 9 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), ... present at the OneMedPlace Finance Forum on Tuesday, January ... visit www.onemedplace.com . , Dr. Randal Chase, president ... 8:45 am PST on the development of its superior ...
Cached Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3
(Date:9/30/2014)... it comes to using marijuana, new research, involving mice ... Journal of Leukocyte Biology , suggests ... that you should. That,s because a team of Italian ... do serious long-term damage to the immune system. This ... diseases, such as multiple sclerosis, inflammatory bowel disease and ...
(Date:9/30/2014)... Mass. , Sept. 30, 2014 /PRNewswire/ ... control solutions for the biotech and power ... its new RECONN Bioprocess Manager, an easy-to-use ... solution geared towards bioprocess development laboratories. ... have disparate bioreactor and analyzer systems. Accessing ...
(Date:9/29/2014)... exposure to tar tended to be lower for smokers ... exposure to nicotine tended to be lower. , Slim ... several countries around the world. Previous studies have shown ... smoke of these cigarettes are lower than those in ... the smoke are not necessarily linked to a reduced ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2
... the Arctic is boosted by global warming, it,s not enough ... permafrost beneath the surface, University of Florida researchers have found ... thawing of permafrost in a warming world. Twice as ... the atmosphere today, and what happens to it as it ...
... the first time in mammalian brain cells, researchers at ... in building the circuitry that relays signals through the ... aging process in the brain, the researchers say. Additionally, ... discovery paves the way for faster progress toward identifying ...
... back on a shark" is the take home message from ... Erich Ritter of the Shark Research Institute and Raid Amin ... that sharks can comprehend body orientation and therefore know whether ... to approach and possibly attack their prey from the blind ...
Cached Biology News:UF researchers' experiment is first to simulate warming of Arctic permafrost 2UF researchers' experiment is first to simulate warming of Arctic permafrost 3Gene found to be crucial for formation of certain brain circuitry 2Sharks prefer to sneak up from behind, study shows 2
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU....
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
... Antibody to CRF The ... ovine CRF sequence that it ... fibres are found in the ... brain in colchicine treated 4% ...
Biology Products: